The allure of achieving incredible gains in short time periods has many investors looking to strike it rich picking biotech stocks. But it's also attracted the attention of many fund companies, which are looking to capitalize on the average investor's interest in a more diversified form of biotech exposure. While my personal preference for the longer-term investor looking to invest in biotech is to target a basket of stocks, in the following video, I offer up an opinion on the biotech ETF that best captures the essence of biotech investing.
Motley Fool Returns
Stock Advisor S&P 500
5 Years 50% 36%
17+ years 337% 93%
Stock Advisor launched in February of 2002. Returns as of 11/11/2019.Join Stock Advisor